A Study of MF101 in Postmenopausal Women

Status unconfirmed · Phase 3 · Has a placebo group

Conditions studied: Hot Flushes, Vasomotor Symptoms

In brief

This phase 3a study is designed to assess the safety and efficacy of MF101 on the frequency of moderate to severe hot flushes in postmenopausal women.

Key facts

Study ID
NCT00906308
Run by
Bionovo
People needed
1200
Starts
2011-10-01
Last updated by the study team
2012-02-08

Who can join

Age: 40 and older, up to 65. Sex: female. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.